These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31948863)

  • 1. Immunosuppression strategies in elderly renal transplant recipients.
    Camilleri B; Pararajasingam R; Buttigieg J; Halawa A
    Transplant Rev (Orlando); 2020 Apr; 34(2):100529. PubMed ID: 31948863
    [No Abstract]   [Full Text] [Related]  

  • 2. The arduous road to achieving an immunosuppression-free state in kidney transplant recipients.
    Ansari MJ; Sayegh MH
    Nat Clin Pract Nephrol; 2007 Sep; 3(9):464-5. PubMed ID: 17646858
    [No Abstract]   [Full Text] [Related]  

  • 3. Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.
    Na R; Laaksonen MA; Grulich AE; Webster AC; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
    Clin Transplant; 2015 Nov; 29(11):978-90. PubMed ID: 26278925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elderly Kidney Transplant Recipients: Single-Center Experience in the Middle East.
    Gheith O; Halim MA; Al-Otaibi T; El-Sayed A; Nair P; Mahmoud T; Fathy A; Hameed MA; Samy A; El Serwy N; Nagib AM
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):135-141. PubMed ID: 30777539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression in elderly renal transplant recipients: are current regimens too aggressive?
    Meier-Kriesche HU; Kaplan B
    Drugs Aging; 2001; 18(10):751-9. PubMed ID: 11735622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ABCs of Immunosuppression: A Primer for Primary Care Physicians.
    Malat G; Culkin C
    Med Clin North Am; 2016 May; 100(3):505-18. PubMed ID: 27095642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction type and outcomes for kidney graft and patient survival in recipients with prior lung transplantation in the United States.
    Riad S; Goswami U; Jackson S; Hertz M; Matas A
    J Heart Lung Transplant; 2020 Feb; 39(2):157-164. PubMed ID: 31837899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End-stage renal disease in 2010: Innovative approaches to improve outcomes in transplantation.
    Shapiro R
    Nat Rev Nephrol; 2011 Feb; 7(2):68-70. PubMed ID: 21278714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing the significant interaction between XR tacrolimus and fluconazole in kidney transplant recipients.
    Lange NW; Hedvat J; Tsapepas DS; Salerno DM
    Clin Transplant; 2020 Aug; 34(8):e14001. PubMed ID: 32564404
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunosuppression in the kidney transplant. Old drugs and new acquisitions].
    Rodríguez Ferrero M; Valderrábano F
    Rev Clin Esp; 1997 Oct; 197(10):703-12. PubMed ID: 9424669
    [No Abstract]   [Full Text] [Related]  

  • 11. Need for optimized immunosuppression in elderly kidney transplant recipients.
    Lehner LJ; Staeck O; Halleck F; Liefeldt L; Bamoulid J; Budde K
    Transplant Rev (Orlando); 2015 Oct; 29(4):237-9. PubMed ID: 26411381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
    Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
    Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression in liver transplant recipients with renal impairment.
    Duvoux C; Pageaux GP
    J Hepatol; 2011 May; 54(5):1041-54. PubMed ID: 21145927
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus rescue therapy for refractory rejection in renal transplant recipients.
    Hong JC; Kahan BD
    Transplant Proc; 2001; 33(1-2):1033. PubMed ID: 11267178
    [No Abstract]   [Full Text] [Related]  

  • 17. Prednisone-free maintenance immunosuppression in obese kidney transplant recipients.
    Matas AJ; Vock DM
    Clin Transplant; 2019 Oct; 33(10):e13668. PubMed ID: 31310030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up.
    Citterio F; Scatà MC; Romagnoli J; Pozzetto U; Nanni G; Castagneto M
    Transplant Proc; 2002 Aug; 34(5):1685-6. PubMed ID: 12176535
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of mycophenolate mofetil on recurrent rejection in kidney transplant patients.
    Vasquez EM; Sifontis NM; Pollak R; Benedetti E
    Clin Transplant; 2001 Aug; 15(4):253-7. PubMed ID: 11683819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance immunosuppressive therapy in adult renal transplantation: a single center analysis.
    Säemann MD; Sunder-Plassmann G
    Transpl Immunol; 2008 Nov; 20(1-2):14-20. PubMed ID: 18804533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.